Novartis Recalls Lescol XL Tablets Due to Chemical Contamination
Novartis is recalling Lescol XL tablets contaminated with Darocur 1173, a photocuring agent found in ink on shrink-wrap sleeves.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury or property damage reports, or high-risk contamination.
Plain-English summary
Novartis Pharmaceuticals Corporation has recalled specific bottles of Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg. The recall involves 46,812 bottles of the product, which is distributed nationwide and in Puerto Rico. The affected product is identified by Product Code 707136, Lot Number F0017, and an expiration date of 01/31/2015.
The recall was initiated due to chemical contamination with Darocur 1173, a photocuring agent used in inks on shrink-wrap sleeves. This contamination affected physician sample bottles of several Novartis products, including Lescol XL, Diovan, Exforge, Exforge HCT, Stalevo, Tekturna, and Tekturna HCT.
Consumers and healthcare providers should check their inventory for the specific lot and product code listed above. If the product matches the recalled description, it should be discontinued and returned to the pharmacy or supplier for replacement or refund.
The recalled product
- Product
- Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg per tablet, 7 tablets per bottle, Physician Sample-Not For Sale, Rx only. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936…
- Manufacturer
- Novartis Pharmaceuticals Corp.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 46,812
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Product code: 707136
- Lot Number: F0017
- Exp 01/31/2015
Distribution
Part of a larger recall action
This product is one of 15 recalled by Novartis Pharmaceuticals Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 15 products in this recall →Related recalls
Same manufacturer · Novartis Pharmaceuticals Corp.
See all →- SevereNovartis Withdraws SANDIMMUNE Oral Solution Bottles Due to Crystallization
FDA (Drugs) · 2023-09-27
- CriticalNovartis Recalls Promacta Oral Suspension Due to Peanut Cross-Contamination
FDA (Drugs) · 2019-05-29
- ModerateNovartis Recalls Pilocarpine Hydrochloride Ophthalmic Solution for Impurity Failures
FDA (Drugs) · 2017-05-03
- LowNovartis Recalls Isopto Carpine Eye Drops for Impurity Failures
FDA (Drugs) · 2017-05-03
- LowNovartis Recalls Dexmethylphenidate HCl Extended-Release Capsules for Dissolution Failure
FDA (Drugs) · 2015-09-23
Same hazard · chemical contamination
See all →- ModerateAvid Medical Recalls 30 DAVINCI LAP/GYN Kits for Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls Craniotomy Packs Due to Potential Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls Plastic Trays Due to Lubricant Contamination
FDA (Devices) · 2026-10-14
- HighFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
- SevereFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
Similar recalls
- LowNovartis Recalls Dexmethylphenidate HCl Extended-Release Capsules for Dissolution Failure
FDA (Drugs) · 2015-09-23
- LowNovartis Recalls Cataflam Tablets Due to Illegible Ink Identification
FDA (Drugs) · 2014-08-13
- LowNovartis Recalls Maalox Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28
- LowNovartis Recalls Maalox Antacid Tablets Due to Illegible Packaging Labels
FDA (Drugs) · 2013-08-28
- SevereTorrent Pharma Recalls Losartan Potassium Tablets Due to Impurity
FDA (Drugs) · 2019-10-09
- LowNovartis Recalls Maalox Extra Strength Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28